US233A - Improvement in plows - Google Patents

Improvement in plows Download PDF

Info

Publication number
US233A
US233A US233DA US233A US 233 A US233 A US 233A US 233D A US233D A US 233DA US 233 A US233 A US 233A
Authority
US
United States
Prior art keywords
landside
improvement
plows
edge
share
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
Publication date
Application granted granted Critical
Publication of US233A publication Critical patent/US233A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B61RAILWAYS
    • B61FRAIL VEHICLE SUSPENSIONS, e.g. UNDERFRAMES, BOGIES OR ARRANGEMENTS OF WHEEL AXLES; RAIL VEHICLES FOR USE ON TRACKS OF DIFFERENT WIDTH; PREVENTING DERAILING OF RAIL VEHICLES; WHEEL GUARDS, OBSTRUCTION REMOVERS OR THE LIKE FOR RAIL VEHICLES
    • B61F17/00Lubrication specially adapted for axle-boxes of rail vehicles
    • B61F17/02Lubrication specially adapted for axle-boxes of rail vehicles with oil
    • B61F17/04Lubrication by stationary devices
    • B61F17/06Lubrication by stationary devices by means of a wick or the like
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S149/00Explosive and thermic compositions or charges
    • Y10S149/117Smoke or weather composition contains resin

Definitions

  • Fig. 3 is a view of the landside of my plow, within a recess or depression in which I place a reversing cutter, g g g, the general form of which is that of a triangle, either end of which may be turned forward, so as to constitute the cutting-edge formed by the junction of the mold-board and landside of the plow.
  • This reversing cutter may be fastened in its place by making it hollow, so as to receive the part h of the landside, allowing space enough between the piece h and the cutter .to insert a wedge or wedges, i.
  • the edges of h are made dovetailing or beveled, to clip the inner edges of g and holditfirmlyagainstthelandsidewhen wedged.
  • One of theedges of g may reach to the bottom of the landside; or it may stand a little above it, having the strip of iron 9 below it, which strip in this case forms a side of the recess.
  • the reversing cutter received into a recess or the landside and capable of having either of its edges presented forward, so as to form the cutting-edge of the plow, and secured in its place on the landside by a wedge or wedges, or in any other manner which may be preferred.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Piles And Underground Anchors (AREA)

Description

May 29, 1915.
DRAWING A careful search has been made this day for the original drawing or a photolithographic copy of the same,
for the purpose of reproducing the said drawing to form a part of this book, but at this time nothing can be found from which a reproduction can be made.
Finis D Morris,
Chief of Division E.
NrTED PATENT Fries.
BANOROFT WOODCOCK, OF MOUNT PLEASANT, PENNSYLVANIA.
IMPROVEMENT IN PLOWS.
To all whom it may concern:
Be it known that I, BANOROF'J. WooDcooK, of Mount Pleasant, in the county of Westmoreland. and State of Pennsylvania, have invented certain Improvements in Flows; and I do hereby declare that the following is a full and exact description thereof.
The share which I use is the same in its general form as that described by me in the specification annexed to Letters Patent granted to me on the 23d day of November, 1836; but it dilfers therefrom in its transverse section a b, Figure 2, through the part represented by the dotted line a b, Fig. 1. The face on each side has its surface flat from each cutting-edge to a shoulder, represented by the line 0 d on one side and on the opposite side by the dotted line of. By this means I am enabled to make the share so thin throughout its width that as it wears up toward the mold-board it is still sufficiently soon its edge to pass freelythrough the ground. It has two holes, xx, through it, by one or the other of which it is bolted to the mold-board.
Fig. 3 is a view of the landside of my plow, within a recess or depression in which I place a reversing cutter, g g g, the general form of which is that of a triangle, either end of which may be turned forward, so as to constitute the cutting-edge formed by the junction of the mold-board and landside of the plow. This reversing cutter may be fastened in its place by making it hollow, so as to receive the part h of the landside, allowing space enough between the piece h and the cutter .to insert a wedge or wedges, i. The edges of h are made dovetailing or beveled, to clip the inner edges of g and holditfirmlyagainstthelandsidewhen wedged. One of theedges of g may reach to the bottom of the landside; or it may stand a little above it, having the strip of iron 9 below it, which strip in this case forms a side of the recess.
.1 have also made an improvement in the manner of making the renewable point. For the mode in which I formerly made it I refer to the description thereof in the Letters Patent above named. I now prepare a V-formed piece of iron or steel, which fits onto the shank 70, Fig. 3, embracing it on both sides, as shown at Z l,.and fastened to it by a rivet passing through the whole. The renewable point is thus rendered more permanent than upon the the former plan, and the shank is perfectly protected from grinding out in wear.
In order to secure the landside to the moldboard, 1 cast the fitting parts with dovetail junctures in such a way as that, when secured together by wedges passed between cheeks adapted to that purpose, the parts interlock,
'and are retained firmly in their places.
What I claim in reference to the share is- 1. Making it with plain surfaces instead of curved ones, in the manner described, continuing such surfaces to the shoulder on each side, so as to leave the metal throughout so thin that when it wears off by use the share will still present a thin edge to the ground.
2. The reversing cutter, received into a recess or the landside and capable of having either of its edges presented forward, so as to form the cutting-edge of the plow, and secured in its place on the landside by a wedge or wedges, or in any other manner which may be preferred.
3. The mode of forming the renewable point, as herein. specifically set forth.
BANC-ROFT VOODCOUK. Witnesses:
THos. I. JoNEs, M. E. J ONES.
US233D Improvement in plows Expired - Lifetime US233A (en)

Publications (1)

Publication Number Publication Date
US233A true US233A (en) 1837-06-14

Family

ID=2060512

Family Applications (1)

Application Number Title Priority Date Filing Date
US233D Expired - Lifetime US233A (en) Improvement in plows

Country Status (1)

Country Link
US (1) US233A (en)

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120267016A1 (en) * 2011-04-19 2012-10-25 Lombardi John L Nontoxic Obscurant Compositions and Method of Using Same
WO2014153063A1 (en) 2013-03-14 2014-09-25 Amgen Inc. AGLYCOSYLATED Fc-CONTAINING POLYPEPTIDES
WO2016166360A1 (en) 2015-04-17 2016-10-20 Bayer Pharma Aktiengesellschaft Bispecific antibody constructs for cdh3 and cd3
EP3456743A1 (en) 2013-05-30 2019-03-20 Kiniksa Pharmaceuticals, Ltd. Oncostatin m receptor antigen binding proteins
WO2019070901A1 (en) 2017-10-04 2019-04-11 Amgen Inc. Transthyretin immunoglobulin fusions
WO2020025596A1 (en) 2018-07-31 2020-02-06 Amgen Research (Munich) Gmbh Dosing regimen for bcma-cd3 bispecific antibodies
WO2020025792A1 (en) 2018-08-03 2020-02-06 Amgen Research (Munich) Gmbh Antibody constructs for cldn18.2 and cd3
WO2020025532A1 (en) 2018-07-30 2020-02-06 Amgen Research (Munich) Gmbh Prolonged administration of a bispecific antibody construct binding to cd33 and cd3
WO2021007150A1 (en) 2019-07-08 2021-01-14 Amgen Inc. Multispecific transthyretin immunoglobulin fusions
WO2021030602A1 (en) 2019-08-13 2021-02-18 Amgen Inc. Interleukin-2 muteins for the expansion of t-regulatory cells
EP3819007A1 (en) 2019-11-11 2021-05-12 Amgen Research (Munich) GmbH Dosing regimen for anti-bcma agents
WO2021108647A1 (en) 2019-11-27 2021-06-03 Crispr Therapeutics Ag Methods of synthesizing rna molecules
WO2021127262A1 (en) 2019-12-17 2021-06-24 Amgen Inc. Dual interleukin-2 /tnf receptor agonist for use in therapy
WO2021150824A1 (en) 2020-01-22 2021-07-29 Amgen Research (Munich) Gmbh Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
EP3865514A1 (en) 2015-07-31 2021-08-18 Amgen Research (Munich) GmbH Bispecific antibody constructs binding dll3 and cd3
EP3912999A1 (en) 2015-07-31 2021-11-24 Amgen Research (Munich) GmbH Bispecific antibody constructs binding egfrviii and cd3
WO2021243320A2 (en) 2020-05-29 2021-12-02 Amgen Inc. Adverse effects-mitigating administration of a bispecific antibody construct binding to cd33 and cd3
WO2022103781A1 (en) 2020-11-10 2022-05-19 Amgen Inc. Methods for administering a bcma x cd3 binding molecule
EP4101928A1 (en) 2021-06-11 2022-12-14 Bayer AG Type v rna programmable endonuclease systems
WO2022258753A1 (en) 2021-06-11 2022-12-15 Bayer Aktiengesellschaft Type v rna programmable endonuclease systems
EP4144841A1 (en) 2021-09-07 2023-03-08 Bayer AG Novel small rna programmable endonuclease systems with impoved pam specificity and uses thereof
WO2023078968A1 (en) 2021-11-03 2023-05-11 Affimed Gmbh Bispecific cd16a binders
WO2023079493A1 (en) 2021-11-03 2023-05-11 Affimed Gmbh Bispecific cd16a binders
EP4219562A2 (en) 2015-07-31 2023-08-02 Amgen Research (Munich) GmbH Antibody constructs for flt3 and cd3
WO2023237587A1 (en) 2022-06-10 2023-12-14 Bayer Aktiengesellschaft Novel small type v rna programmable endonuclease systems
EP4327885A2 (en) 2015-07-31 2024-02-28 Amgen Research (Munich) GmbH Antibody constructs for msln and cd3

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120267016A1 (en) * 2011-04-19 2012-10-25 Lombardi John L Nontoxic Obscurant Compositions and Method of Using Same
WO2014153063A1 (en) 2013-03-14 2014-09-25 Amgen Inc. AGLYCOSYLATED Fc-CONTAINING POLYPEPTIDES
EP4349864A2 (en) 2013-05-30 2024-04-10 Kiniksa Pharmaceuticals, Ltd. Oncostatin m receptor antigen binding proteins
EP3456743A1 (en) 2013-05-30 2019-03-20 Kiniksa Pharmaceuticals, Ltd. Oncostatin m receptor antigen binding proteins
EP3971212A1 (en) 2013-05-30 2022-03-23 Kiniksa Pharmaceuticals, Ltd. Oncostatin m receptor antigen binding proteins
EP4276116A2 (en) 2015-04-17 2023-11-15 Amgen Research (Munich) GmbH Bispecific antibody constructs for cdh3 and cd3
WO2016166360A1 (en) 2015-04-17 2016-10-20 Bayer Pharma Aktiengesellschaft Bispecific antibody constructs for cdh3 and cd3
EP4219562A2 (en) 2015-07-31 2023-08-02 Amgen Research (Munich) GmbH Antibody constructs for flt3 and cd3
EP4327885A2 (en) 2015-07-31 2024-02-28 Amgen Research (Munich) GmbH Antibody constructs for msln and cd3
EP3912999A1 (en) 2015-07-31 2021-11-24 Amgen Research (Munich) GmbH Bispecific antibody constructs binding egfrviii and cd3
EP3865514A1 (en) 2015-07-31 2021-08-18 Amgen Research (Munich) GmbH Bispecific antibody constructs binding dll3 and cd3
WO2019070901A1 (en) 2017-10-04 2019-04-11 Amgen Inc. Transthyretin immunoglobulin fusions
WO2020025532A1 (en) 2018-07-30 2020-02-06 Amgen Research (Munich) Gmbh Prolonged administration of a bispecific antibody construct binding to cd33 and cd3
WO2020025596A1 (en) 2018-07-31 2020-02-06 Amgen Research (Munich) Gmbh Dosing regimen for bcma-cd3 bispecific antibodies
WO2020025792A1 (en) 2018-08-03 2020-02-06 Amgen Research (Munich) Gmbh Antibody constructs for cldn18.2 and cd3
WO2021007150A1 (en) 2019-07-08 2021-01-14 Amgen Inc. Multispecific transthyretin immunoglobulin fusions
EP4385573A2 (en) 2019-08-13 2024-06-19 Amgen Inc. Interleukin-2 muteins for the expansion of t-regulatory cells
WO2021030602A1 (en) 2019-08-13 2021-02-18 Amgen Inc. Interleukin-2 muteins for the expansion of t-regulatory cells
WO2021094000A1 (en) 2019-11-11 2021-05-20 Amgen Research (Munich) Gmbh Dosing regimen for anti-bcma agents
EP3819007A1 (en) 2019-11-11 2021-05-12 Amgen Research (Munich) GmbH Dosing regimen for anti-bcma agents
WO2021108647A1 (en) 2019-11-27 2021-06-03 Crispr Therapeutics Ag Methods of synthesizing rna molecules
WO2021127262A1 (en) 2019-12-17 2021-06-24 Amgen Inc. Dual interleukin-2 /tnf receptor agonist for use in therapy
WO2021150824A1 (en) 2020-01-22 2021-07-29 Amgen Research (Munich) Gmbh Combinations of antibody constructs and inhibitors of cytokine release syndrome and uses thereof
WO2021243320A2 (en) 2020-05-29 2021-12-02 Amgen Inc. Adverse effects-mitigating administration of a bispecific antibody construct binding to cd33 and cd3
WO2022103781A1 (en) 2020-11-10 2022-05-19 Amgen Inc. Methods for administering a bcma x cd3 binding molecule
WO2022258753A1 (en) 2021-06-11 2022-12-15 Bayer Aktiengesellschaft Type v rna programmable endonuclease systems
EP4101928A1 (en) 2021-06-11 2022-12-14 Bayer AG Type v rna programmable endonuclease systems
EP4144841A1 (en) 2021-09-07 2023-03-08 Bayer AG Novel small rna programmable endonuclease systems with impoved pam specificity and uses thereof
WO2023078968A1 (en) 2021-11-03 2023-05-11 Affimed Gmbh Bispecific cd16a binders
WO2023079493A1 (en) 2021-11-03 2023-05-11 Affimed Gmbh Bispecific cd16a binders
WO2023237587A1 (en) 2022-06-10 2023-12-14 Bayer Aktiengesellschaft Novel small type v rna programmable endonuclease systems

Similar Documents

Publication Publication Date Title
US233A (en) Improvement in plows
US476A (en) Bancroft woodcock
US85A (en) Bancroft woodcock
US260A (en) Improvement in plows
US501A (en) Improvement in plows
US184A (en) Improvement in spokeshaves
US273A (en) Improvement in plows
US4127A (en) Improvement in plows
US295A (en) Improvement in the construction of self-sharpening plows
US1004238A (en) Subsoil-plow.
US638A (en) Improvement in self-sharpening plows
US259A (en) Improvement in plows
US1208267A (en) Plow.
US604A (en) Improvement in plows
US2132A (en) Improvement in the construction of plows
US1008A (en) Improvement in double-mold-board plows
US1469808A (en) Dipper tooth
US954A (en) Mode of laying off and dressing the runners of millstones
US327A (en) Improvement in plows
US1360A (en) Improvement in plows
US922A (en) Improvement in plows
US750385A (en) Joseph naidul
US992034A (en) Detachable shovel-tooth point.
USX6338I1 (en) Edmund m
US837494A (en) Plow.